Boston Scientific (BSX) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $72.91 --0%
Revenue Growth %: +13.7%
Financial Fact:
Amortization expense: 136M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Revenue Growth %: +13.7%
Financial Fact:
Amortization expense: 136M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.15 billion.
GUIDANCE:
Boston Scientific sees Q4 2022 EPS of $0.45-$0.48, versus the consensus of $0.49.
Boston Scientific sees FY2022 EPS of $1.71-$1.74, versus the consensus of $1.76.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $85 at Mizuho
- Ladder Capital (LADR) Tops Q1 EPS by 4c
- Morphic Holding, Inc. (MORF) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
